title: Transduction of long-term-engrafting human hematopoietic stem cells by retroviral vectors.
abstract: Gene therapy using retroviral vectors to transfer functional exogenous genes into hematopoietic stem cells (HSCs) promises to provide a permanent cure for a wide array of both hematopoietic and nonhematopoietic disorders by virtue of the fact that retroviral vectors permanently integrate into the host cell genome and HSCs are able to self-renew and give rise to differentiated progeny throughout the life span of the patient. However, for transduction and genomic integration to occur, the target cells must undergo cell division and express the appropriate retroviral receptor, requirements that have thus far hindered attempts at inserting exogenous genes into human HSCs in vitro. In the present studies, we used the fetal sheep xenograft model of human hematopoiesis to evaluate whether human long-term engrafting HSCs could be transduced in vivo, within a fetal microenvironment. We transplanted adult human bone marrow-derived CD34(+)Lin(-) cells into preimmune fetal sheep recipients and subsequently (19 days later) administered clinical-grade murine retroviral vector supernatants to these fetal hematopoietic chimeras. Our results demonstrate that this approach successfully transduced adult human HSCs within all seven sheep that survived the procedure, and that these transduced HSCs had the ability to serially engraft primary, secondary, and tertiary fetal sheep recipients. Transgene expression persisted throughout the serial transplantation. The successful in vivo transduction of long-term engrafting human HSCs with the existing generation of murine retroviral vectors has significant implications for developing new approaches to pre- and postnatal gene therapy.
authors.affiliation: Department of Animal Biotechnology, University of Nevada, Reno, NV 89520, USA.
authors.forename: Christopher D
authors.initials: CD
authors.lastname: Porada
authors.forename: Nam D
authors.initials: ND
authors.lastname: Tran
authors.forename: Graça
authors.initials: G
authors.lastname: Almeida-Porada
authors.forename: Hudson A
authors.initials: HA
authors.lastname: Glimp
authors.forename: John S
authors.initials: JS
authors.lastname: Pixley
authors.forename: Yi
authors.initials: Y
authors.lastname: Zhao
authors.forename: W French
authors.initials: WF
authors.lastname: Anderson
authors.forename: Esmail D
authors.initials: ED
authors.lastname: Zanjani
mesh_terms: D018952:Antigens, CD34 / Q000096:biosynthesis; D001854:Bone Marrow Cells / Q000378:metabolism; D002478:Cells, Cultured; D005434:Flow Cytometry; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods*; D006412:Hematopoietic Stem Cells / Q000378:metabolism* / Q000821:virology; D006801:Humans; D008856:Microscopy, Fluorescence; D012190:Retroviridae / Q000235:genetics*; D013997:Time Factors; D019076:Transgenes; D001616:beta-Galactosidase / Q000378:metabolism
chemical_list: D018952:Antigens, CD34; D001616:beta-Galactosidase